Compugen net loss widens in Q2

|About: Compugen Ltd. (CGEN)|By:, SA News Editor

Compugen (CGEN) Q2 results: Revenues: $0; R&D Expense: $7.1M (+29.1%); SG&A: $2.2M (+10.0%); Operating Loss: ($9.3M) (-32.9%); Net Loss: ($9.2M) (-39.4%); Loss Per Share: ($0.18) (-38.5%); Quick Assets: $46.1M (-25.0%).

No guidance given.

Subscribe for full text news in your inbox